Sorted By:

Relevance


Pfizer’s Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts

PhRMA  |  Press Release

His career at Lilly began in 1979 as a senior organic chemist in process research and development, a department he later led in 1982.
https://www.phrma.org/press-release/pfizer-s-jeffrey-kindler-becomes-phrma-board-chairman-christopher-viehbacher-john-lechleiter-assume-new-posts

Consumers Will Pay More Out Of Pocket Next Year For Specialty Drugs

Access Better Coverage  |  From Our Network

While there is no standard definition of such drugs outside of the Medicare program, they are often expensive medications used to treat serious, chronic illnesses, such as multiple sclerosis, rheumatoid arthritis, hemophilia, some cancers and hepatitis C.
http://www.accessbettercoverage.org/social-news/consumers-will-pay-more-out-of-pocket-next-year-for-specialty-drugs

Ian Read

PhRMA  |  Biography

Ian began his career with Pfizer in 1978 as an operational auditor.
https://www.phrma.org/biography/ian-read1

PhRMA Statement on PCAST Innovation Report

PhRMA  |  Press Release

Research-intensive, science-driven sectors such as ours play an important role in helping to support students pursuing careers in the STEM fields. 
https://www.phrma.org/press-release/phrma-statement-on-pcast-innovation-report

Stephen J. Ubl to Lead PhRMA as Next President and CEO

PhRMA  |  Press Release

Ubl began his Washington career on Capitol Hill, where he worked for U.S.
https://www.phrma.org/press-release/stephen-j-ubl-to-lead-phrma-as-next-president-and-ceo

Ask About Adherence: Q&A with PhRMA Foundation Grant Awardee - Marisa Schauerhamer

PhRMA  |  Blog Post

DOUGHERTY: How has/will the PhRMA Foundation grant advance your career in adherence research?
http://catalyst.phrma.org/ask-about-adherence-qa-with-phrma-foundation-grant-awardee-marisa-schauerhamer

Ramona Sequeira

PhRMA  |  Biography

During her career, she led several successful product launches, managed relationships with partners, improved operational performance and workforce engagement.
https://www.phrma.org/biography/ramona-sequeira

Lisa M. Tate, CAE

PhRMA  |  Biography

Tate has enjoyed a career of more than 25 years in public affairs, health care advocacy, and non-profit management. 
https://www.phrma.org/biography/lisa-m-tate-cae

PhRMA and The ALS Association Report More Than 560 Medicines in Development for Rare Diseases

PhRMA  |  Press Release

Examples of the medicines currently in development include: 151 for rare cancers and 82 for rare blood cancers; 148 for genetic disorders, including cystic fibrosis and spinal muscular atrophy; 38 for neurological disorders, including ALS and seizures; 31 for infectious diseases, including rare bacterial infections and hepatitis; and 25 for autoimmune diseases, including systemic sclerosis and juvenile arthritis.
https://www.phrma.org/press-release/phrma-and-the-als-association-report-more-than-560-medicines-in-development-for-rare-diseases

PhRMA Foundation: 2015 in review

PhRMA  |  Blog Post

It has given me the individual resources necessary to conduct this valuable work while at the same time affording me the opportunity to continue down the path of building a career as an independent research investigator.” – Matthew J.
http://catalyst.phrma.org/phrma-foundation-2015-in-review

Rod Hunter Joins PhRMA as Senior VP, International Advocacy

PhRMA  |  Press Release

Earlier in his career, he served as an assistant to U.S.
https://www.phrma.org/press-release/rod-hunter-joins-phrma-as-senior-vp-international-advocacy

Patient voices missing from media conversation about prescription drug abuse

PhRMA  |  Blog Post

The people writing prescriptions should be educated, in their initial training and throughout their career, on the proper prescribing of pain medications, signs of potential abuse and the nuances of pain management.
http://catalyst.phrma.org/patient-voices-missing-from-media-conversation-about-prescription-drug-abuse

World AIDS Day 2014: Transforming the Trajectory of Disease

PhRMA  |  Blog Post

This had a profound impact on me, and caused me, like so many of my colleagues in HIV medicine, to focus my career on trying to find treatments for AIDS.
http://catalyst.phrma.org/world-aids-day-2014-transforming-the-trajectory-of-disease

Turning Your Cancer Against Itself

From Hope To Cures  |  From Our Network

“The hope is that we can turn cancers from ones that don’t attract immune cells into those that do.
http://www.fromhopetocures.org/turning-your-cancer-against-itself

Joaquin Duato

PhRMA  |  Biography

America’s Top 10 Hispanic Business Leaders by Hispanic Career World. 
https://www.phrma.org/biography/joaquin-duato

PhRMA Fills Key Leadership Position; Dr. David Wheadon To Head Scientific Team

PhRMA  |  Press Release

He began his career at Eli Lilly & Company, where he held positions in clinical research and development.
https://www.phrma.org/press-release/phrma-fills-key-leadership-position-dr-david-wheadon-to-head-scientific-team

John J. Castellani to Lead PhRMA as New President & CEO

PhRMA  |  Press Release

He began his career as an environmental scientist at General Electric.
https://www.phrma.org/press-release/john-j-castellani-to-lead-phrma-as-new-president-and-ceo

Cost-Sharing Reductions Unevenly Applied Across Services in Exchange Plans

Access Better Coverage  |  From Our Network

However, wide variation even exists among carriers that lowered deductibles.
http://www.accessbettercoverage.org/reports/cost-sharing-reductions-unevenly-applied-across-services-in-exchange-plans

New report: Decade of breakthroughs in cancer

PhRMA  |  Blog Post

Similarly, the pathways by which cancers evade our immune system are present among a variety of cancers, and we are seeing the application of immunotherapies across a number of disease areas.
http://catalyst.phrma.org/new-report-decade-of-breakthroughs-in-cancer

David Brennan Elected PhRMA Board Chairman

PhRMA  |  Press Release

He began his J&J career in 1979 as a product manager for the company’s affiliate, Janssen Pharmaceutica, in Australia.
https://www.phrma.org/press-release/david-brennan-elected-phrma-board-chairman

PhRMA Announces Two New Research Associate Members

PhRMA  |  Press Release

The company has approved medicines to treat patients with solid and hematologic cancers, and a pipeline of anticancer compounds at various stages of clinical development. 
https://www.phrma.org/press-release/phrma-announces-two-new-research-associate-members

Building on the promise of personalized medicine

PhRMA  |  Blog Post

Cancer is an area where personalized medicines are having a particularly big impact, driving tremendous advances for patients with highly aggressive cancers, like non-small cell lung cancer (NSCLC).
http://catalyst.phrma.org/building-on-the-promise-of-personalized-medicine

Biopharmaceutical Companies Recognized as Meaningful Places to Work

PhRMA  |  Blog Post

Get career opportunity updates and general news info here.
http://catalyst.phrma.org/biopharmaceutical-companies-recognized-as-meaningful-places-to-work

Four Facts: Value and Cost of Medicines

PhRMA  |  Blog Post

One of the most complex and deadly cancers – leukemia – can now be treated with groundbreaking medicines, which have nearly tripled the five-year survival rate for patients.
http://catalyst.phrma.org/four-facts-value-and-cost-of-medicines

PhRMA Statement on Personalized Medicine Research

PhRMA  |  Press Release

It requires significant investment beyond the traditional R&D process – itself costly and lengthy – such as technologies associated with target validation, early toxicology markers, and micro-sequencing.
https://www.phrma.org/press-release/phrma-statement-on-personalized-medicine-research

You have reviewed the first 175 results out of 263. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 next